NO SET ASIDE USED.

EUROFINS DISCOVERY SERVICES NORTH AMERICA, LLC - LAB TESTING SERVICE: D2L AND D3 HUMAN DOPAMINE RADIOLIGAND BINDING ASSAY

PIID: 75N95C22P00008Solicitation ID: 22-000052
Signed Date: Nov 2, 2021Effective Date: Nov 2, 2021End Date: Closed on Sep 22, 2023
Award $
$16K
Vendor
EUROFINS DISCOVERY SERVICES NORTH AMERICA, LLC
NAICS
541380
Signed Date
Nov 2, 2021

Key Details

Dollars Obligated
$16,292.42
Base & All Options
$16,292.42
Awarding Sub-Agency
National Institutes of Health
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
NOT COMPETED UNDER SAP
Number of Offers
1

Description

LAB TESTING SERVICE: D2L AND D3 HUMAN DOPAMINE RADIOLIGAND BINDING ASSAY

Context & Analysis

On Nov 2, 2021, Department of Health and Human Services obligated $16,292.42 to EUROFINS DISCOVERY SERVICES NORTH AMERICA, LLC for lab testing service: d2l and d3 human dopamine radioligand binding assay. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.

Contractor Information

UEI: HF4LCAU68M93
Location: SAINT CHARLES, MO

Stay Updated

Get notified about new opportunities matching your interests.

Related